secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001193125-25-017264
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Verrica receives Nasdaq deficiency notice; stock below $1 for 30 days, 180-day cure period until July 23, 2025
--------------------------------------------------------------------------------

- Nasdaq notified Verrica on Jan 24, 2025 that bid price closed below $1.00 for 30 consecutive days, violating Listing Rule 5450(a)(1).
- Company has 180 days (until July 23, 2025) to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not cured, Verrica may transfer to Nasdaq Capital Market by paying $5,000 fee and meeting other standards except bid price.
- Company is considering options including reverse stock split and application to transfer to Nasdaq Capital Market.
- No immediate impact on listing; delisting risk if compliance not achieved within cure periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525017264/0001193125-25-017264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525017264/d913894d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-017264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer